Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice

Neuropharmacology. 2018 Aug:138:232-244. doi: 10.1016/j.neuropharm.2018.06.020. Epub 2018 Jun 18.

Abstract

Since Cav3.2 T-type Ca2+ channels (T-channels) expressed in the primary afferents and CNS contribute to intractable pain, we explored T-channel-blocking components in distinct herbal extracts using a whole-cell patch-clamp technique in HEK293 cells stably expressing Cav3.2 or Cav3.1, and purified and identified sophoraflavanone G (SG) as an active compound from SOPHORAE RADIX (SR). Interestingly, hop-derived SG analogues, (2S)-6-prenylnaringenin (6-PNG) and (2S)-8-PNG, but not naringenin, also blocked T-channels; IC50 (μM) of SG, (2S)-6-PNG and (2S)-8-PNG was 0.68-0.75 for Cav3.2 and 0.99-1.41 for Cav3.1. (2S)-6-PNG and (2S)-8-PNG, but not SG, exhibited reversible inhibition. The racemic (2R/S)-6-PNG as well as (2S)-6-PNG potently blocked Cav3.2, but exhibited minor effect on high-voltage-activated Ca2+ channels and voltage-gated Na+ channels in differentiated NG108-15 cells. In mice, the mechanical allodynia following intraplantar (i.pl.) administration of an H2S donor was abolished by oral or i.p. SR extract and by i.pl. SG, (2S)-6-PNG or (2S)-8-PNG, but not naringenin. Intraperitoneal (2R/S)-6-PNG strongly suppressed visceral pain and spinal ERK phosphorylation following intracolonic administration of an H2S donor in mice. (2R/S)-6-PNG, administered i.pl. or i.p., suppressed the neuropathic allodynia induced by partial sciatic nerve ligation or oxaliplatin, an anti-cancer agent, in mice. (2R/S)-6-PNG had little or no effect on open-field behavior, motor performance or cardiovascular function in mice, and on the contractility of isolated rat aorta. (2R/S)-6-PNG, but not SG, was detectable in the brain after their i.p. administration in mice. Our data suggest that 6-PNG, a hop component, blocks T-channels, and alleviates neuropathic and visceral pain with little side effects.

Keywords: 6-Prenylnaringenin; Neuropathic pain; Sophoraflavanone G; T-type calcium channel; Visceral pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Non-Narcotic / chemistry
  • Analgesics, Non-Narcotic / isolation & purification
  • Analgesics, Non-Narcotic / pharmacology*
  • Animals
  • Calcium Channel Blockers / chemistry
  • Calcium Channel Blockers / isolation & purification
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, T-Type / genetics
  • Calcium Channels, T-Type / metabolism
  • Disease Models, Animal
  • Flavonoids / chemistry
  • Flavonoids / isolation & purification
  • Flavonoids / pharmacology*
  • HEK293 Cells
  • Humans
  • Humulus
  • Hyperalgesia / drug therapy
  • Hyperalgesia / metabolism
  • Male
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neuralgia / drug therapy*
  • Neuralgia / metabolism
  • Phytochemicals / chemistry
  • Phytochemicals / isolation & purification
  • Phytochemicals / pharmacology
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Random Allocation
  • Rats, Wistar
  • Visceral Pain / drug therapy*
  • Visceral Pain / metabolism

Substances

  • 6-prenylnaringenin
  • Analgesics, Non-Narcotic
  • Cacna1h protein, mouse
  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • Flavonoids
  • Phytochemicals
  • Plant Extracts